deltatrials
Completed NA INTERVENTIONAL 3-arm NCT01058278

Impact Post-operative Treatment on Intraocular Pressure Post-SLT on Patients With Primary Open-angle Glaucoma (SLT)

Impact of the Post-operative Treatment on the Intraocular Pressure Post Selective Laser Trabeculoplasty (SLT) on Patients With Primary Open-angle Glaucoma

Sponsor: CHU de Quebec-Universite Laval

Updated 6 times since 2017 Last updated: Feb 26, 2016 Started: Mar 31, 2008 Primary completion: Jun 30, 2012 Completion: Dec 31, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Glaucoma and Inflammatory Response, this trial is completed. The trial is conducted by CHU de Quebec-Universite Laval and has accumulated 6 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Jul 2017 · 6 months · monthly snapshotCompleted~Jul 2017 – ~Jun 2018 · 11 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Jun 2018 — Jan 2021 [monthly]

    Completed NA

  5. Jul 2017 — Jun 2018 [monthly]

    Completed NA

Show 1 earlier version
  1. Jan 2017 — Jul 2017 [monthly]

    Completed NA

    First recorded

Mar 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • CHU de Quebec-Universite Laval
  • Canadian Glaucoma Clinical Research Council
  • Pfizer
Data source: CHU de Quebec-Universite Laval

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations